IPO

IPO Synopsis

Q-Line Biotech Ltd
Registered Office: 298-281 Transport Nagar Kanpur,#NAME? , Lucknow - 226012 , Uttar Pradesh , India.
Phone : +91 522 2435 570   Fax:
Email :  compliance@qlinebiotech.com  
Website :  www.qlinebiotech.com
Initial public offer of upto 62,53,200 equity shares of face value of Rs10/- each (the "Equity Shares") of Q-Line Biotech Limited ("the Company" or "QLBL" or "the Issuer") at an issue price of Rs326-343 per equity share (including share premium of Rs316-333 per equity share) for cash, aggregating up to Rs203.85-214.48 Crores ("Public Issue") out of which 3,13,200 equity shares of face value of Rs10/- each, at an issue price of Rs326-343 per equity share for cash, aggregating Rs10.21-10.74 Crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. Issue of 59,40,000 equity shares of face value of Rs10/- each, at an issue price of Rs326-343 per equity share for cash, aggregating upto Rs193.64-203.74 Crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute 26.81% and 25.46% respectively of the post- issue paid-up equity share capital of the company. The company, in consultation with the book running lead managers, may consider a pre-ipo placement of up to 8,00,000 equity shares for cash consideration ("pre-ipo placement") prior to filing of the pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the book running lead managers. If the pre-ipo placement is undertaken, the number of equity shares issued pursuant to the pre-ipo placement shall be reduced from the issue, subject to compliance with Rule 19(2)(b) of the securities contracts (Regulation) rules, 1957, as amended ("scrr"). Price Band: Rs326 to Rs343 per equity share of face value Rs10/- each. The floor price (Rs326) is 32.6 times the face value of the equity shares and the cap price (Rs343) is 34.3 times of the face value of the equity shares. Bids can be made for a minimum of 800 equity shares and in multiples of 400 equity shares thereafter.
Issue Money Payable On
Opens On Closes On Application Allotment
21-May-26 25-May-26 Rs 326.00-343.00 Rs 0.00-0.00
Minimum Application for shares in Nos :800  Further Multiples of :400
  (Rs Cr) Lead Managers to the Issue
Project Cost 0.00
Hem Securities Limited
Project Financed through Current Offer 203.85
Post Issue Equity Share Capital 23.33
Issue Price Rs 326.00
Projects
To meet Working Capital requirements General corporate purposes
Repayment of certain borrowing availed by the Company, in part or full
Promoted By Listing At Registrar to the Issue
  Saurabh Garg
  Amita Garg
  Ayush Garg
 NSE - SME
No Data Found.
Tuesday, May 19, 2026 12:00:00 AM
Adani Ports1762.55comprofit(-1.37)%
      
Asian Paints2600.20comprofit(-0.48)%
      
Axis Bank1238.55comprofit(0.01)%
      
Bajaj Finance923.45comprofit(0.29)%
      
Bajaj Finserv1749.80comprofit(-0.22)%
      
Bharat Electro..423.15comprofit(-0.83)%
      
Bharti Airtel1913.60comprofit(-1.26)%
      
Eternal247.05comprofit(2.40)%
      
HCL Technologi..1179.10comprofit(2.82)%
      
HDFC Bank762.75comprofit(-0.75)%
      
Hind. Unilever2231.95comprofit(-1.02)%
      
ICICI Bank1240.95comprofit(-0.80)%
      
Infosys1196.90comprofit(4.77)%
      
Interglobe Avi..4231.50comprofit(-1.04)%
      
ITC310.30comprofit(0.05)%
      
Kotak Mah. Ban..381.85comprofit(-2.51)%
      
Larsen & Toubr..3918.00comprofit(-0.02)%
      
M & M3091.00comprofit(0.25)%
      
Maruti Suzuki12967.45comprofit(-0.36)%
      
NTPC389.20comprofit(0.41)%
      
Power Grid Cor..298.60comprofit(0.73)%
      
Reliance Indus..1322.30comprofit(-0.97)%
      
SBI948.50comprofit(0.90)%
      
Sun Pharma.Ind..1882.15comprofit(-1.21)%
      
Tata Steel209.30comprofit(-0.26)%
      
TCS2327.55comprofit(1.90)%
      
Tech Mahindra1466.90comprofit(2.55)%
      
Titan Company4102.15comprofit(-1.63)%
      
Trent4068.25comprofit(0.89)%
      
UltraTech Cem.11368.65comprofit(-1.57)%
      

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)